BHE Q4 2025 Earnings Call Summary | Stock Taper
Logo
BHE

BHE — Benchmark Electronics, Inc.

NYSE


Q4 2025 Earnings Call Summary

February 3, 2026

Summary of BHE Q4 2025 Earnings Call

1. Key Financial Results and Metrics

  • Q4 Revenue: $704 million, up 7% year-over-year and at the higher end of guidance.
  • Q4 Non-GAAP EPS: $0.71, exceeding guidance of $0.62 to $0.68.
  • Gross Margin: 10.6%, up 50 basis points sequentially and 20 basis points year-over-year.
  • Operating Margin: 5.5%, up 70 basis points sequentially and 40 basis points year-over-year.
  • Full Year Revenue: $2.66 billion, flat compared to the prior year, but with improved momentum in the second half.
  • Full Year Non-GAAP EPS: $2.40, up 5% year-over-year.
  • Free Cash Flow: $85 million for the fiscal year, with a cash balance of $322 million at year-end.

2. Strategic Updates and Business Highlights

  • Sector Performance: Strong growth in Aerospace and Defense (A&D) and Medical sectors, with A&D revenue up 19% year-over-year and Medical up 7%.
  • Focus Areas: The company targets five core high-value markets and avoids commoditized sectors. Significant wins in space, medical technology, and enterprise AI were highlighted.
  • Operational Efficiency: Improved working capital efficiency and a reduced cash conversion cycle to 67 days, down 10 days sequentially.
  • Investments: Continued investment in global precision technology, including a new building in Penang to support semi cap recovery.

3. Forward Guidance and Outlook

  • Q1 2026 Revenue Guidance: Expected between $655 million and $695 million, representing a 7% year-over-year increase at the midpoint.
  • Gross Margin Guidance: Anticipated between 10.4% and 10.6%.
  • Non-GAAP EPS Guidance: Expected in the range of $0.53 to $0.59.
  • Long-term Outlook: Positive momentum in bookings and operational execution is expected to drive growth, particularly in the Medical and A&D sectors.

4. Bad News, Challenges, or Points of Concern

  • Semi Cap Sector: Experienced an 8% decline quarter-over-quarter and 14% year-over-year, though recovery is anticipated in 2026.
  • Impairment Charges: An $11.1 million non-cash impairment recorded due to the end of life of certain programs.
  • Tax Corrections: Identified errors in prior tax calculations leading to an increase in income tax expense, though this did not affect cash flow or reported earnings.

5. Notable Q&A Insights

  • Demand Dynamics: Management expressed increased confidence in the Medical and A&D sectors, with indications of improved demand in Semi Cap and Industrial sectors.
  • Margin Management: Emphasis on operational leverage as revenue grows, with expectations that SG&A expenses will not increase at the same rate as revenue.
  • Future Growth in Semi Cap: Management is optimistic about a recovery in the Semi Cap sector, with potential orders expected to ramp up within one to three months.
  • CEO Transition: Jeffrey Benck announced his departure as CEO, expressing confidence in the leadership transition to David Moezidis, who will continue to drive the company's momentum.

This summary encapsulates the key financial metrics, strategic initiatives, outlook, challenges, and insights from the Q&A session, providing a balanced view of Benchmark's performance and future direction.